20,139 Followers on Owler
OverviewCompetitorsAcquisitionsFundingInvestmentsNews & Insights

AstraZeneca Acquisitions

AstraZeneca has acquired 25 companies and its latest acquisition was EsoBiotec B.V. on Mar 2025

Unlock 22 more acquisitions →
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
EsoBiotec B.V.

Mar 2025

Source »
$999.5M
-

-

FibroGen China

Feb 2025

Source »
$160M
-
Amolyt Pharma SAS

Mar 2024

Source »
$800M
Amolyt Pharma is a France-based biotechnology company that develops and commercializes therapeutic peptides for the treatment of endocrine diseases.
Fusion Pharmaceuticals, Inc.

Mar 2024

Source »
$2B
Fusion Pharma is a Canada-based biopharmaceutical company that researches and develops radiation therapies for the treatment of cancer.
Icosavax, Inc.

Dec 2023

Source »
$1.1B
Icosavax is a Washington-based biotechnology company that researches and develops VLP vaccines for the treatment of respiratory diseases.

Frequently Asked Questions about AstraZeneca

  1. What companies did AstraZeneca acquire?

    Companies acquired by AstraZeneca include EsoBiotec, and Amolyt Pharma

  2. How many acquisitions does AstraZeneca have?

    AstraZeneca has acquired 25 companies including EsoBiotec, and Amolyt Pharma.

  1. How many acquisitions did AstraZeneca make in 2025?

    In 2025 AstraZeneca acquired 2 companies including EsoBiotec and .